The University of Plymouth, the AHSN Network and Boehringer Ingelheim, has launched evidence-based recommendations to drive inclusive digital health tech innovation. How to involve and engage patients in digital health tech innovation, An Evidence Based Guide sets standards to ensure patients are at the centre of digital transformation.
As digital health innovators seek to demonstrate that their technologies can add value to the system, the scale of the challenge is clear: as of April 2022, the UK has over 300,000 healthcare apps live on the market, yet only 6 in 10 innovators consult patients before deciding to develop a new digital health tool.
Alongside the fundamental catalysts for digital transformation including cost, accessibility, convenience, and advances in technology, lie the real drivers of change – the patients and the clinicians that serve them – who can too often be at the periphery of the conversation.
Matt Whitty, chief executive of the Accelerated Access Collaborative and director of innovation, Research & Life Sciences, NHS England & NHS Improvement said: “Through research and innovation, we can improve patient outcomes and reduce health inequalities. Patient-centred digital technology is an increasingly important aspect of a dynamic and sustainable health system. By ensuring patients are involved in developing these digital technologies we will create solutions that best meet their needs. I hope this guide will help support innovative digital technology development across our health service.”
The new guide has combined the results of a systematic literature review, advisory panels, and multi-stakeholder input to produce four clear principles (ENACT) around patient and public involvement and engagement (PPIE). The principles make it clear how to involve patients in product innovation and make recommendations around critical issues such as data privacy, intellectual property, inclusivity, reimbursement, useability, and recruitment of patients for health technology entrepreneurs.
The guide helps with the initial digital development and puts in place processes to support ongoing product improvement. By adopting the core principles, digital innovators can continually evolve their product, better communicate its value to the system, and crucially improve patient trust in the technologies created.
Zainab Garba-Sani, a patient and NHS manager involved in the development of the guide, said: “The pandemic brought digital transformation in healthcare into many people’s lives for the first time and now, more than ever, there is a need to push for patient empowerment in the innovation process. Without it, we risk amplifying health inequities and missing out on the great potential to address disparities.”
The robust academic foundation for the guide was provided by the University of Plymouth’s research ‘Meaningful patient and public involvement in digital health innovation, implementation and evaluation: a systematic review’ which was recently published in the international journal Health Expectations. The review was followed up by a Delphi study to consensually evolve the ENACT principles. The collaborative effort with Boehringer Ingelheim and AHSN helped stress test the principles, refine, and produce the guide.
Professor Arunangsu Chatterjee, dean of digital transformation, University of Leeds and visiting professor of digital health & education at the University of Plymouth, said: “Digital health innovation is still fairly new territory and there is a need for clarity to ensure development that is inclusive of patients. Bringing together the academic rigour and expertise of organisations like ours, the commercial expertise of Boehringer Ingelheim and the community network of the AHSN has accelerated positive change, and the development of this resource has been a true partnership.”
Richard Stubbs, vice-chair of the AHSN Network added: “To drive true change in our healthcare system, a patient-centred approach must be at the heart. The guide makes key recommendations in this area. Simple steps such as building relationships with community leaders and influencers can help innovators engage with patients and families in under-represented demographics. I hope this guide can support inclusive innovation and make a positive impact in the digital transformation of the UK healthcare system.”
Uday Bose, country managing director at Boehringer Ingelheim UK & Ireland, said: “Critical to the success of any efforts we undertake for patients is to engage and actively involve them from the start. Modern healthcare systems cannot deal with any wasted time or effort, so we hope that this guide helps the system to create patient-centric innovations in an efficient manner.”